1. Home
  2. TMDX vs BMA Comparison

TMDX vs BMA Comparison

Compare TMDX & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • BMA
  • Stock Information
  • Founded
  • TMDX 1998
  • BMA 1966
  • Country
  • TMDX United States
  • BMA Argentina
  • Employees
  • TMDX N/A
  • BMA N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BMA Commercial Banks
  • Sector
  • TMDX Health Care
  • BMA Finance
  • Exchange
  • TMDX Nasdaq
  • BMA Nasdaq
  • Market Cap
  • TMDX 3.9B
  • BMA 4.2B
  • IPO Year
  • TMDX 2019
  • BMA 2006
  • Fundamental
  • Price
  • TMDX $115.69
  • BMA $43.07
  • Analyst Decision
  • TMDX Buy
  • BMA Buy
  • Analyst Count
  • TMDX 11
  • BMA 4
  • Target Price
  • TMDX $125.40
  • BMA $60.50
  • AVG Volume (30 Days)
  • TMDX 958.8K
  • BMA 978.7K
  • Earning Date
  • TMDX 10-27-2025
  • BMA 08-27-2025
  • Dividend Yield
  • TMDX N/A
  • BMA 2.58%
  • EPS Growth
  • TMDX 2163.11
  • BMA N/A
  • EPS
  • TMDX 2.02
  • BMA 0.50
  • Revenue
  • TMDX $531,292,000.00
  • BMA $2,573,406,817.00
  • Revenue This Year
  • TMDX $38.87
  • BMA N/A
  • Revenue Next Year
  • TMDX $20.70
  • BMA $3.01
  • P/E Ratio
  • TMDX $57.33
  • BMA $9.29
  • Revenue Growth
  • TMDX 48.09
  • BMA N/A
  • 52 Week Low
  • TMDX $55.00
  • BMA $38.30
  • 52 Week High
  • TMDX $146.98
  • BMA $118.42
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.53
  • BMA 39.60
  • Support Level
  • TMDX $109.77
  • BMA $39.30
  • Resistance Level
  • TMDX $115.90
  • BMA $53.88
  • Average True Range (ATR)
  • TMDX 4.84
  • BMA 3.07
  • MACD
  • TMDX -0.12
  • BMA 0.50
  • Stochastic Oscillator
  • TMDX 31.21
  • BMA 30.62

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

Share on Social Networks: